Home Newsfeeds Stephens & Co. Downgrades FB Financial to Equal-Weight

Stephens & Co. Downgrades FB Financial to Equal-Weight

Stephens & Co. analyst Matt Olney downgrades FB Financial (NYSE:FBK) from Overweight to Equal-Weight.

byBenzinga Newsdesk

December 13, 2022

1 minute read

Stephens & Co. analyst Matt Olney downgrades FB Financial (NYSE:FBK) from Overweight to Equal-Weight.

News
Tech

Joe Rogan Says Elon Musk Is His Favorite Billionaire: ‘I Will Buy Teslas As Long As They Sell Them Just To Support That Dude’

By Ananya Gairola

May 23, 12:11 AM

Joe Rogan praised Elon Musk as his favorite billionaire on his podcast, stating he will continue to support Musk by buying Tesla vehicles.

TSLA

News

Desktop Metal Launches The ETEC Pro XL, An Industrial Polymer 3D Printer That Drives New Affordability In Premium DLP Technology At Half The Price Of Its Predecessor

By Benzinga Newsdesk

October 10, 8:38 AM

Now available below $40,000, the ETEC Pro XL delivers extreme accuracy, resolution, and surface finish in a large build area with the high throughput speeds for which area-wide DLP technology is knownAdditional updates

Baird Maintains Outperform on RumbleON, Lowers Price Target to $10

By Benzinga Newsdesk

November 25, 8:53 AM

Baird analyst Craig Kennison maintains RumbleON (NASDAQ:RMBL) with a Outperform and lowers the price target from $15 to $10.

RMBL

HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $15 Price Target

By Benzinga Newsdesk

February 16, 7:09 AM

HC Wainwright & Co. analyst Yi Chen reiterates ProPhase Labs (NASDAQ:PRPH) with a Buy and maintains $15 price target.

PRPH

Stephens & Co. Downgrades FB Financial to Equal-Weight

Related Posts

Joe Rogan Says Elon Musk Is His Favorite Billionaire: ‘I Will Buy Teslas As Long As They Sell Them Just To Support That Dude’

Desktop Metal Launches The ETEC Pro XL, An Industrial Polymer 3D Printer That Drives New Affordability In Premium DLP Technology At Half The Price Of Its Predecessor

Baird Maintains Outperform on RumbleON, Lowers Price Target to $10

HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $15 Price Target